Full Press Release Details
IDEAYA Announces Oral Presentation at the New Drugs on the Horizon Series at AACR 2025 for IDE275 GSK959 , a Phase 1 Werner Helicase Inhibitor.
IDYA
IDEAYA Announces Oral Presentation at the New Drugs on the Horizon Series at AACR 2025 for IDE275 GSK959 , a Phase 1 Werner Helicase Inhibitor
Key Takeaway: IDEAYA Announces Oral Presentation at the New Drugs on the Horizon Series at AACR 2025 for IDE275 GSK959 , a Phase 1 Werner Helicase Inhibitor